BioNJ Annual Dinner Meeting Committee

BioNJ Members collaborate to plan the agenda for the February BioNJ Annual Dinner Meeting and Innovation Celebration; a celebratory dinner meeting and networking event honoring New Jersey’s innovators and the Patients who inspire them.

Committee Members:

Marsh, Inc. – Bill DeStefano, Vice President, Life Science Practice
VelocIT – Darek Hahn, President & CEO

Amicus Therapeutics, Inc. – Jayne Gershkowitz, Chief Patient Advocate
Amicus Therapeutics, Inc. – Paul Howard, PhD – Director of Public Policy
Amicus Therapeutics, Inc. – Michael Losow, JD, MBA, Director, Patient & Professional Advocacy
Ashton Tweed, LTD – Jordan Warshafsky, MBA, Partner
Chemical & Pharmaceutical Solutions – James Bruno, MBA, Managing Director
Colliers International – Jack Callahan, Associate Director
Deloitte – Brian Wilcomes, CPA, Partner
Eli Lilly & Company – Tracy Henrikson, MBA, Vice President, Corporate Communications
EY – Tony Torrington, CPA, Partner
EY – Joel Wagner, CPA, Assurance Senior Manager
Infinity Resources, LLC – Harriet Maphet, MBA, President
LeaderStrong – Marshall Calman, MBA, PCC, Co-Founder & Principal
LeaderStrong – Jack Levitt, MBA, EMTM, Co-Founder & Principal
New Jersey Commission of Science, Innovation & Technology  – Judith Sheft, MSc, MBA, Executive Director
New Jersey Institute of Technology (NJIT) –  Takeyah Young, MEng, CSM, Technology Licensing, Office of Business Incubation and Commercialization
Soligenix, Inc. – Christopher Schaber, Ph.D., President & CEO